放射性药品不良反应调查第39次报告(2016年第42次调查)。

Kaku igaku. The Japanese journal of nuclear medicine Pub Date : 2018-01-01 DOI:10.18893/kakuigaku.rp.1873

Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura

{"title":"放射性药品不良反应调查第39次报告(2016年第42次调查)。","authors":"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura","doi":"10.18893/kakuigaku.rp.1873","DOIUrl":null,"url":null,"abstract":"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2016 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 977 institutions among 1,235 to which the questionnaire had been sent. Nine cases of adverse reactions were reported. A total of 1,052,650 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 0.9. No case of deficient products was reported.","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[The 39th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 42nd Survey in 2016)].\",\"authors\":\"Hiroshi Matsuda, T. Uehara, H. Okazawa, S. Mizumura, K. Yokoyama, M. Yoshimura\",\"doi\":\"10.18893/kakuigaku.rp.1873\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2016 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 977 institutions among 1,235 to which the questionnaire had been sent. Nine cases of adverse reactions were reported. A total of 1,052,650 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 0.9. No case of deficient products was reported.\",\"PeriodicalId\":17738,\"journal\":{\"name\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kaku igaku. The Japanese journal of nuclear medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18893/kakuigaku.rp.1873\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kaku igaku. The Japanese journal of nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18893/kakuigaku.rp.1873","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

本调查旨在调查2016财年日本放射性药物不良反应的发生率。该报告是根据对核医学机构的问卷调查得出的。在收到调查表的1 235所院校中，有977所院校作出了答复。报告不良反应9例。共报告了1,052,650起放射性药物管理事件。不良反应发生率为每10万例0.9。未发现缺陷产品。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[The 39th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 42nd Survey in 2016)].

This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2016 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 977 institutions among 1,235 to which the questionnaire had been sent. Nine cases of adverse reactions were reported. A total of 1,052,650 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 0.9. No case of deficient products was reported.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Kaku igaku. The Japanese journal of nuclear medicine Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The main scope of JSNM is the appropriate development of the application of radioactive substances and stable nuclides in medicine. Towards this scope, JSNM promotes the exchange of idea and information, and researches in nuclear medicine. JSNM are interested in the international collaboration for the development of nuclear medicine. Through the activities, JSNM contributes to the medicine, as well as humanity, not only in Japan but also in any countries over the world.

期刊最新文献

[The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)].